Shire announced plans to lease the iconic Kendall Square, Boston headquarters now occupied by Sanofi Genzyme.
Shire plans to move into the 343,00 sq ft building in early 2019, using the space for research, clinical development, medical affairs and business development, all working closely to push for innovation in the rare disease space.
“By expanding our presence in Cambridge, with its close proximity to best-in-class hospitals, research institutions, universities and a thriving biotechnology community, we will strengthen our ties with the early innovators around us to shape the next generation of breakthrough therapies for patients with high unmet needs," Shire CEO Dr. Flemming Ornskov said.
Per Shire's website, the company is actively hiring, with nearly 400 positions currently designated for Massachusetts.
Read the company press release